Adrie van Bokhoven, PhD The PCA3 assay could be particularly useful in finding prostate cancer sooner in African Americans. DENVER – The PCA3 urine test may improve early detection of prostate cancer, ...

In the European Randomised Study of Screening for Prostate Cancer (ERSPC) trial, PCA3 was assessed as a first line-screening test. 40 While the positive predictive values of a PCA3 score of 10 or ...

Data Bridge Market Research conducted a recent market intelligence study, thoroughly analysing the Prostate Cancer Antigen 3 (PCA3) Test Market. The newly published report employs an appealing layout ...

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group found insufficient evidence to recommend prostate cancer antigen 3 (PCA3) testing to inform decisions for when ...

Prostate cancer is one of the largest killers among males worldwide. Until recently, prostate cancer diagnosis has relied on a combination of prostate-specific antigen (PSA) level, digital rectal ...

March 30, 2007 — A new test for prostate cancer, which measures levels of the prostate cancer gene 3 (PCA3) in urine, may be useful in diagnosing prostate cancer in men who have elevated serum levels ...

Currently, early detection of prostate cancer depends on an abnormal digital rectal examination and an elevated prostate-specific-antigen (PSA) level requiring a prostate biopsy, often associated with ...

Please provide your email address to receive an email when new articles are posted on . The PCA3 urine test accurately predicted whether a prostate biopsy would detect cancer in a prospective ...

Alkaline phosphatase (ALP) normalization and overall survival in patients with bone metastases from castration-resistant prostate cancer (CRPC) treated with radium-223. Germ-line single nucleotide ...

Global Prostate Cancer Antigen 3 (PCA3) Test Market Overview: For drawing up sustainable, money-making, and profitable business strategies, the winning Prostate Cancer Antigen 3 (PCA3) Test Market ...

Diagnostic combines PCA3 and three other RNAs, including a gene fusion, according to Cancer Research paper. An experimental biomarker test more accurately detects prostate cancer than any other ...

QUEBEC CITY, May 25, 2012 /CNW Telbec/ - DiagnoCure Inc. (TSX: CUR), a Quebec life sciences company that develops and commercializes high-value cancer diagnostic tests, reported that the PROGENSA PCA3 ...